Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...

Clene is partnering with APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8® in ALS p ...

The number of confirmed measles cases in western Texas grew to 146, and it is possibly spreading to the central part of the ...

About two-thirds of Americans are getting too little or too much sleep, risking their health, a new study suggests.

Learn more about whether Alnylam Pharmaceuticals, Inc. or argenx SE is a better investment based on AAII's A+ Investor grades ...

New Jersey Governor Phil Murphy has ordered flags fly half-staff to honor the life of a Garden State legislator who died on Feb. 19. Find out more ...

DNLI reports a narrower-than-expected loss for the fourth quarter of 2024. Denali remains on track to submit a BLA for ...

Today, Benzinga's options scanner spotted 11 options trades for Cytokinetics. This is not a typical pattern. The sentiment among these major traders is split, with 18% bullish and 72% bearish. Among ...

In California, some individuals qualify for both Medicare and Medi-Cal, a status known as dual eligibility or "Medi-Medi." ...

Following Pfizer’s acquisition, Biohaven’s valuation skyrocketed under Vlad Coric. Find out why BHVN stock’s growth potential ...

Mission Therapeutics is down to its clinical assets MTX652 and MTX325, which work by disabling a key enzyme that interferes with the cell’s normal process of removing faulty or dysfunctional ...

Clene (NASDAQ: CLNN) announced that CEO Rob Etherington and CFO Morgan Brown will present at the Investor Summit Virtual on March 11, 2025. The even ...